Moving away from trypsin-like serine proteases, DPPIV (Dipeptidyl peptidase IV), FAP (Fibroblast activation protein) and PEP (Prolyl endopeptidase) have emerged as potentially important players in cancer [70]. This evidence concerns the gene FAP and cancer.